索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]雷浩,成尚霖,尚斌,等.感染性心内膜炎外科治疗进展[J].国际心血管病杂志,2021,05:265-269.
点击复制

感染性心内膜炎外科治疗进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年05期
页码:
265-269
栏目:
综述
出版日期:
2021-10-01

文章信息/Info

Title:
-
作者:
雷浩;成尚霖;尚斌;马捷
030001 太原,山西医科大学(雷浩),山西医科大学第二医院心胸外科(成尚霖、尚斌、马捷)
Author(s):
-
关键词:
感染性心内膜炎;  外科治疗;  早期手术;  技术创新
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.05.003
文献标识码:
-
摘要:
感染性心内膜炎是非传染性心内膜和心脏瓣膜感染,是心脏瓣膜病中最严重、最具破坏性以及高死亡率的疾病。外科手术是该类疾病的治疗方式之一,但手术时机仍未达成共识。随着对疾病认识的加深,多项研究表明早期手术可提高瓣膜修复的成功率,降低各种严重并发症的发生,降低患者死亡率。瓣膜成形技术逐渐成熟,自体心包瓣叶的重建技术为治疗瓣膜修复提供了有效的新方法。治疗复杂的主动脉瓣膜病变,结合应用Kyorin-coagulator、Perceval无缝合瓣膜等新辅助技术,可为不适宜传统手术治疗或治疗效果不佳的患者提供更多新的选择方案,提高治疗效果。
Abstract:
-

参考文献/References

[1] Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis[J]. Clin Infect Dis, 2000, 30(4):633-638.
[2] Nakatani S, Ohara T, Ashihara K, et al. JCS 2017 guideline on prevention and treatment of infective endocarditis[J]. Circ J, 2019, 83(8):1767-1809.
[3] Bovenzi F, Borelli L, Cortigiani L. Site of entry and surgical timing in infective endocarditis[J]. J Cardiovasc Med(Hagerstown), 2018, 19(Suppl 1):e16-e18.
[4] Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis[J]. J Am Coll Cardiol, 2017, 69(3):325-344.
[5] Zhigalov K, Sá MPBO, Kadyraliev B, et al. Surgical treatment of infective endocarditis in the era of minimally invasive cardiac surgery and transcatheter approach: an editorial[J]. J Thorac Dis, 2020, 12(3):140-142.
[6] Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association[J]. Circulation, 2015, 132(15), 1435-1486.
[7] 王鹏, 卢静海, 王贺玲, 等. 感染性心内膜炎368例临床分析[J]. 中华心血管病杂志, 2014, 42(2):140-144.
[8] 陈星伟, 刘亚欣, 于欢, 等. 阜外医院感染性心内膜炎300例临床特征分析[J]. 中国循环杂志, 2018, 33(11):1102-1107.
[9] 曹安强, 罗勇, 袁武, 等. 感染性心内膜炎不同手术时机外科治疗的方案效果比较[J]. 中国心血管病研究, 2019, 17(4):368-372.
[10] Liang F, Song B, Liu R, et al. Optimal timing for early surgery in infective endocarditis: a meta-analysis[J]. Interact Cardiovasc Thorac Surg. 2016, 22(3):336-345.
[11] Chu VH, Park LP, Athan E, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis[J]. Circulation, 2015, 131(2):131-140.
[12] Scheggi V, Alterini B, Olivotto I, et al. Embolic risk stratification and prognostic impact of early surgery in left-sided infective endocarditis[J]. Eur J Intern Med, 2020, 78:82-87.
[13] ?stergaard L, Dahl A, Fosb?l E, et al. Residual vegetation after treatment for left-sided infective endocarditis and subsequent risk of stroke and recurrence of endocarditis[J]. Int J Cardiol, 2019, 293:67-72.
[14] Fosb?l EL, Park LP, Chu VH, et al. The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis[J]. Eur Heart J, 2019, 40(27):2243-2251.
[15] Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis[J]. Nat Rev Dis Primers, 2016, 2:16059.
[16] Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis[J]. N Engl J Med, 2012, 366(26):2466-2473.
[17] Tomic A, Schneider AW, Palmen M, et al. Extensive infective endocarditis of the aortic root and the aortic-mitral continuity: a mitral valve sparing approach[J]. Eur J Cardiothorac Surg, 2017, 51(6):1100-1107.
[18] Volk L, Verghis N, Chiricolo A, et al. Early and intermediate outcomes for surgical management of infective endocarditis[J]. J Cardiothorac Surg, 2019, 14(1):211.
[19] AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery(AATS)consensus guidelines: surgical treatment of infective endocarditis: executive summary[J]. J Thorac Cardiovasc Surg, 2017, 153(6):1241-1258.
[20] Witten JC, Hussain ST, Shrestha NK, et al. Surgical treatment of right-sided infective endocarditis[J]. J Thorac Cardiovasc Surg, 2019, 157(4):1418-1427.
[21] Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery[J]. J Am Coll Cardiol, 2017, 70(24):2953-2960.
[22] Kubota H, Endo H, Ishii H, et al. An infrared coagulator to assist surgical treatment of infective endocarditis[J]. J Thorac Dis, 2019, 11(10):4364-4370.
[23] Hussain ST, Blackstone EH, Pettersson GB. Allografts remain a cornerstone of surgical treatment of invasive and destructive aortic valve infective endocarditis: surgeon and technique do matter[J]. J Thorac Cardiovasc Surg, 2017, 154(6):1900-1901.
[24] Ozaki S, Kawase I, Yamashita H, et al. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium[J]. J Thorac Cardiovasc Surg, 2018, 155(6):2379-2387.
[25] Reuthebuch O, Koechlin L, Schurr U, et al. Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique[J]. Swiss Med Wkly, 2018, 148:w14591.
[26] Mourad F, Shehada SE, Lubarski J, et al. Aortic valve construction using pericardial tissue: short-term single-centre outcomes[J]. Interact Cardiovasc Thorac Surg, 2019, 28(2):183-190.
[27] 陈金淼, 洪涛, 王春生, 等. 人工心脏瓣膜心内膜炎的外科治疗[J]. 中华胸心血管外科杂志, 2015, 31(2):65-68.
[28] Schubert SA, Mehaffey JH, Charles EJ, et al. Mitral valve repair: the french correction versus the American correction[J]. Surg Clin North Am, 2017, 97(4):867-888.
[29] 马璐璐, 朱波, 苗齐, 等. 感染性心内膜炎患者二尖瓣置换和成型术的效果[J]. 临床麻醉学杂志, 2018, 34(10):970-973.
[30] Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: an analysis of the Society of Thoracic Surgeons national database[J]. J Thorac Cardiovasc Surg, 2019, 161(4):1227-1235.
[31] Wang A, Chu VH, Athan E, et al. Association between the timing of surgery for complicated, left-sided infective endocarditis and survival[J]. Am Heart J, 2019, 210:108-116.
[32] Yepez C, Ríos J. Pulmonary valve reconstruction using Ozaki’s technique for infective endocarditis[J]. Eur J Cardiothorac Surg, 2021, 59(4):917-919.
[33] Behmanesh B, Gessler F, Schnoes K, et al. Infective endocarditis in patients with pyogenic spondylodiscitis: implications for diagnosis and therapy[J]. Neurosurg Focus, 2019, 46(1):E2.
[34] Elgalad A, Arafat A, Elshazly T, et al. Surgery for active infective endocarditis of the aortic valve with infection extending beyond the leaflets[J]. Heart Lung Circ, 2019, 28(7):1112-1120.
[35] Rubino AS, Santarpino G, De Praetere H, et al. Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: results of a multicenter study[J]. J Thorac Cardiovasc Surg, 2014, 148(3):865-871.
[36] Weymann A, Konertz J, Laule M, et al. Are sutureless aortic valves suitable for severe high-risk patients suffering from active infective aortic valve endocarditis?[J]. Med Sci Monit, 2017, 23:2782-2787.

备注/Memo

备注/Memo:
通信作者:马捷,E-mail:majie699@163.com
更新日期/Last Update: 2021-10-01